Muscle Biopsy Findings in Combination With Myositis-Specific Autoantibodies Aid Prediction of Outcomes in Juvenile Dermatomyositis

Arthritis and Rheumatology

Volumn 68, Issue 11, 2016, Pages 2806-2816

  Deakin, Claire T ^a   Yasin, Shireena A ^a   Simou, Stefania ^a   Arnold, Katie A ^a   Tansley, Sarah L ^b   Betteridge, Zoe E ^b   McHugh, Neil J ^b   Varsani, Hemlata ^a   Holton, Janice L ^a   Jacques, Thomas S ^a   Pilkington, Clarissa A ^c   Nistala, Kiran ^a   Wedderburn, Lucy R ^a   Armon, Kate ^d   Ellis Gage, Joe ^d   Roper, Holly ^d   Briggs, Vanja ^d   Watts, Joanna ^d   McCann, Liza ^d   Roberts, Ian ^d   Baildam, Eileen ^d   Hanna, Louise ^d   Lloyd, Olivia ^d   Wadeson, Susan ^d   Riley, Phil ^d   McGovern, Ann ^d   Ryder, Clive ^d   Scott, Janis ^d   Thomas, Beverley ^d   Southwood, Taunton ^d   Al Abadi, Eslam ^d   Wyatt, Sue ^d   Jackson, Gillian ^d   Amin, Tania ^d   Wood, Mark ^d   VanRooyen, Vanessa ^d   Burton, Deborah ^d   Davidson, Joyce ^d   Gardner Medwin, Janet ^d   Martin, Neil ^d   Ferguson, Sue ^d   Waxman, Liz ^d   Browne, Michael ^d   Friswell, Mark ^d   Swift, Alison ^d   Jandial, Sharmila ^d   Stevenson, Vicky ^d   Wade, Debbie ^d   Sen, Ethan ^d   Smith, Eve ^d   Qiao, Lisa ^d   Watson, Stuart ^d   Duong, Claire ^d   Venning, Helen ^d   Satyapal, Rangaraj ^d   Stretton, Elizabeth ^d   Jordan, Mary ^d   Mosley, Ellen ^d   Frost, Anna ^d   Crate, Lindsay ^d   Warrier, Kishore ^d   Stafford, Stefanie ^d   Hasson, Nathan ^d   Maillard, Sue ^d   Halkon, Elizabeth ^d   Brown, Virginia ^d   Juggins, Audrey ^d   Smith, Sally ^d   Lunt, Sian ^d   Enayat, Elli ^d   Kassoumeri, Laura ^d   Beard, Laura ^d   Glackin, Yvonne ^d   Almeida, Beverley ^d   Marques, Raquel ^d   Dowle, Stefanie ^d   Papadopoulou, Charis ^d   Murray, Kevin ^d   Ioannou, John ^d   Suffield, Linda ^d   Al Obaidi, Muthana ^d   Lee, Helen ^d   Leach, Sam ^d   Smith, Helen ^d   McMahon, Anne Marie ^d   Chisem, Heather ^d   Kingshott, Ruth ^d   Wilkinson, Nick ^d   Inness, Emma ^d   Kendall, Eunice ^d   Mayers, David ^d   Etherton, Ruth ^d   Bailey, Kathryn ^d   Clinch, Jacqui ^d   Fineman, Natalie ^d   Pluess Hall, Helen ^d   Vallance, Lindsay ^d   Akeroyd, Louise ^d   Leahy, Alice ^d   Collier, Amy ^d   Cutts, Rebecca ^d   De Graaf, Hans ^d   Davidson, Brian ^d   Hartfree, Sarah ^d   Pratt, Danny ^d   more..

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF BATH   (United Kingdom)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^d Great Ormond Street Hospital for Children NHS Foundation Trust and University College London ^*

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CREATINE KINASE; DNA TOPOISOMERASE; MELANOMA DIFFERENTIATION ASSOCIATED GENE 5 ANTIBODY; MYOSITIS SPECIFIC AUTOANTIBODY; NUCLEAR MATRIX PROTEIN; NUCLEAR MATRIX PROTEIN 2 ANTIBODY; SIGNAL RECOGNITION PARTICLE ANTIBODY; SMALL UBIQUITIN LIKE MODIFIER ACTIVATING ENZYME ANTIBODY; TENIDAP; THREONINE TRANSFER RNA LIGASE; TOPOISOMERASE ANTIBODY; TRANSCRIPTION INTERMEDIARY FACTOR 1GAMMA ANTIBODY; UNCLASSIFIED DRUG; CORTICOSTEROID; DNA BINDING PROTEIN; IFIH1 PROTEIN, HUMAN; IMMUNOSUPPRESSIVE AGENT; INTERFERON INDUCED HELICASE C DOMAIN CONTAINING PROTEIN 1; METHOTREXATE; MI-2 ANTIBODIES; NUCLEAR MATRIX PROTEIN 2; SIGNAL RECOGNITION PARTICLE; TRANSCRIPTION FACTOR; TRIM33 PROTEIN, HUMAN;

ANTIBODY BLOOD LEVEL; ARTICLE; CHILD; CLINICAL OUTCOME; CLINICAL STUDY; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; JUVENILE DERMATOMYOSITIS; LONG TERM CARE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MUSCLE BIOPSY; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; VISUAL ANALOG SCALE; COHORT ANALYSIS; DERMATOMYOSITIS; IMMUNOLOGY; ODDS RATIO; PATHOLOGY; PRESCHOOL CHILD; PROTECTION; QUADRICEPS FEMORIS MUSCLE; RISK FACTOR; SEVERITY OF ILLNESS INDEX; UNITED KINGDOM;

ADRENAL CORTEX HORMONES; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DERMATOMYOSITIS; DNA TOPOISOMERASES; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-INDUCED HELICASE, IFIH1; LONGITUDINAL STUDIES; MALE; METHOTREXATE; ODDS RATIO; PROGNOSIS; PROTECTIVE FACTORS; QUADRICEPS MUSCLE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SIGNAL RECOGNITION PARTICLE; THREONINE-TRNA LIGASE; TRANSCRIPTION FACTORS; UNITED KINGDOM;

EID: 84990948130     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39753     Document Type: Article

References (28)

1. Rider LG, Katz JD, Jones OY. Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies. Rheum Dis Clin North Am 2013;39:877–904.
2. Sanner H, Sjaastad I, Flatø B. Disease activity and prognostic factors in juvenile dermatomyositis: a long-term follow-up study applying the Paediatric Rheumatology International Trials Organization criteria for inactive disease and the myositis disease activity assessment tool. Rheumatology (Oxford) 2014;53:1578–85.
3. Martin N, Krol P, Smith S, Murray K, Pilkington CA, Davidson JE, et al. A national registry for juvenile dermatomyositis and other paediatric idiopathic inflammatory myopathies: 10 years' experience; the Juvenile Dermatomyositis National (UK and Ireland) Cohort Biomarker Study and Repository for Idiopathic Inflammatory Myopathies. Rheumatology (Oxford) 2011;50:137–45.
4. Lega JC, Fabien N, Reynaud Q, Durieu I, Durupt S, Dutertre M, et al. The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome. Autoimmun Rev 2014;13:883–91.
5. Tansley SL, Betteridge ZE, Gunawardena H, Jacques TS, Owens CM, Pilkington C, et al. Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study. Arthritis Res Ther 2014;16:R138.
6. Rider LG, Shah M, Mamyrova G, Huber AM, Rice MM, Targoff IN, et al. The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine (Baltimore) 2013;92:223–43.
7. Kobayashi N, Takezaki S, Kobayashi I, Iwata N, Mori M, Nagai K, et al. Clinical and laboratory features of fatal rapidly progressive interstitial lung disease associated with juvenile dermatomyositis. Rheumatology (Oxford) 2015;54:784–91.
8. Hoshino K, Muro Y, Sugiura K, Tomita Y, Nakashima R, Mimori T. Anti-MDA5 and anti-TIF1-γ antibodies have clinical significance for patients with dermatomyositis. Rheumatology (Oxford) 2010;49:1726–33.
9. Gunawardena H, Wedderburn LR, North J, Betteridge Z, Dunphy J, Chinoy H, et al. Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis. Rheumatology (Oxford) 2008;47:324–8.
10. Gunawardena H, Wedderburn LR, Chinoy H, Betteridge ZE, North J, Ollier WE, et al. Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis. Arthritis Rheum 2009;60:1807–14.
11. Tansley SL, Betteridge ZE, Shaddick G, Gunawardena H, Arnold K, Wedderburn LR, et al. Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset. Rheumatology (Oxford) 2014;53:2204–8.
12. Wedderburn LR, Varsani H, Li CK, Newton KR, Amato AA, Banwell B, et al. International consensus on a proposed score system for muscle biopsy evaluation in patients with juvenile dermatomyositis: a tool for potential use in clinical trials. Arthritis Rheum 2007;57:1192–201.
13. Varsani H, Charman SC, Li CK, Marie SK, Amato AA, Banwell B, et al. Validation of a score tool for measurement of histological severity in juvenile dermatomyositis and association with clinical severity of disease. Ann Rheum Dis 2015;74:204–10.
14. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344–7.
15. Rider LG, Koziol D, Giannini EH, Jain MS, Smith MR, Whitney-Mahoney K, et al. Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies. Arthritis Care Res (Hoboken) 2010;62:465–72.
16. Huber AM, Feldman BM, Rennebohm RM, Hicks JE, Lindsley CB, Perez MD, et al. Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies. Arthritis Rheum 2004;50:1595–603.
17. Huber AM, Giannini EH, Bowyer SL, Kim S, Lang B, Lindsley CB, et al. Protocols for the initial treatment of moderately severe juvenile dermatomyositis: results of a Children's Arthritis and Rheumatology Research Alliance Consensus conference. Arthritis Care Res (Hoboken) 2010;62:219–25.
18. Team RDC. R: a language and environment for statistical computing. 2015. URL: http://www.r-project.org.
19. Dinno A. Dunn.test: Dunn's test of multiple comparisons using rank sums. 2015. URL: http://cran.r-project.org/package=dunn.test.
20. Zeger SL, Liang KY, Albert PS. Models for longitudinal data: a generalized estimating equation approach. Biometrics 1988;44:1049–60.
21. Twisk JW, Smidt N, de Vente W. Applied analysis of recurrent events: a practical overview. J Epidemiol Community Health 2005;59:706–10.
22. Twisk JW. Applied longitudinal analysis for epidemiology: a practical guide. 2nd ed. Cambridge: Cambridge University Press; 2003.
23. Hojsgaard S, Halekoh U, Yan J. The R package geepack for generalized estimating equations. J Stat Softw 2006;15:1–11.
24. Barton K. MuMIn: Multi-model inference. 2015. URL: http://cran.r-project.org/package=MuMIn.
25. Pinal-Fernandez I, Casciola-Rosen LA, Christopher-Stine L, Corse AM, Mammen AL. The prevalence of individual histopathologic features varies according to autoantibody status in muscle biopsies from patients with dermatomyositis. J Rheumatol 2015;42:1448–54.
26. Coates AS, Winer EP, Goldhirsch A, Gelber RD, Gnant M, Piccart-Gebhart M, et al. Tailoring therapies: improving the management of early breast cancer: St Gallen International Expert Consensus on the primary therapy of early breast cancer 2015. Ann Oncol 2015;26:1533–46.
27. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 2004;65:521–30.
28. Ruperto N, Pistorio A, Ravelli A, Hasija R, Guseinova D, Filocamo G, et al. Criteria to define response to therapy in paediatric rheumatic diseases. Eur J Clin Pharmacol 2011;67 Suppl 1:125–31.